136
Participants
Start Date
June 1, 2025
Primary Completion Date
October 1, 2026
Study Completion Date
December 1, 2027
analgesic
Patients will receive daily 300 mg pregabalin in divided doses (150 mg/12 hours). Once the patient report mild pain (VAS ≤ 3), the trial for reducing the pregabalin dose will be done. Nonsteroidal anti-inflammatory drug celecoxib (200 mg on request, up to two times daily)27 and tramadol (100 mg on request, up to 400mg daily) will be available for as-needed analgesia.
Tender point infiltration
Lidocaine mixed with diprospan injected into tender points.
Beijing Tiantan Hospital, Beijing
Beijing Tiantan Hospital
OTHER